Literature DB >> 9785513

Phylogenetic analysis of African horse sickness virus segment 10: sequence variation, virulence characteristics and cell exit.

L A Martin1, A J Meyer, R S O'Hara, H Fu, P S Mellor, N J Knowles, P P Mertens.   

Abstract

African horse sickness virus (AHSV) genome segment 10 encodes the non-structural proteins NS3/NS3a, which is involved in release of virus from cells. Full length segment 10 cDNAs were amplified by reverse transcription-polymerase chain reaction, from isolates of AHSV serotypes 2, 3, 4, 5, 7, 8 and 9. These cDNAs were cloned, sequenced and their phylogenetic relationships analysed. High levels of sequence homology were detected in segment 10 from some isolates of different serotypes, confirming that they could be grouped on this basis (serotypes 4, 5, 6 and 9 (group alpha); serotypes 3 and 7 (group beta); serotypes 1, 2, and 8 (group gamma). However, data from bluetongue virus (the prototype orbivirus) indicate that the AHSV serotype is determined exclusively by the structural outer coat proteins VP2 and VP5, encoded by genome segments 2 and 5 respectively. Therefore, as a direct consequence of genome segment reassortment between AHSV strains from different serotypes, the differences observed in segment 10 do not give a reliable indication of virus serotype. Segment 10 of AHSV 3 (virulent) and AHSV 3att (attenuated) were also analysed. These strains, together with AHSV 8, have been used to study of the genetic basis of virulence using reassortment (O'Hara et al., this publication). Virus release studies, using Culicoides cell cultures, indicate that differences in segment 10 of AHSV 3att and 8 can influence the timing of virus release from the infected cell.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785513     DOI: 10.1007/978-3-7091-6823-3_24

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  7 in total

1.  Characterization of a Novel Reassortant Epizootic Hemorrhagic Disease Virus Serotype 6 Strain Isolated from Diseased White-Tailed Deer (Odocoileus virginianus) on a Florida Farm.

Authors:  Thaís C S Rodrigues; Pedro H O Viadanna; Kuttichantran Subramaniam; Ian K Hawkins; Albert B Jeon; Julia C Loeb; Juan M C Krauer; John A Lednicky; Samantha M Wisely; Thomas B Waltzek
Journal:  Viruses       Date:  2022-05-10       Impact factor: 5.818

2.  The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release.

Authors:  Andrew R Beaton; Javier Rodriguez; Y Krishnamohan Reddy; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

3.  Isolation and phylogenetic grouping of equine encephalosis virus in Israel.

Authors:  Karin Aharonson-Raz; Amir Steinman; Velizar Bumbarov; Sushila Maan; Narender Singh Maan; Kyriaki Nomikou; Carrie Batten; Christiaan Potgieter; Yuval Gottlieb; Peter Mertens; Eyal Klement
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

4.  Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan.

Authors:  Siham T Karamalla; Ahmed I Gubran; Ibrahim A Adam; Tamadur M Abdalla; Reem O Sinada; Eltahir M Haroun; Imadeldin E Aradaib
Journal:  BMC Vet Res       Date:  2018-08-01       Impact factor: 2.741

5.  Evidence of Intragenic Recombination in African Horse Sickness Virus.

Authors:  Harry G Ngoveni; Antoinette van Schalkwyk; J J Otto Koekemoer
Journal:  Viruses       Date:  2019-07-18       Impact factor: 5.048

Review 6.  Adaptive strategies of African horse sickness virus to facilitate vector transmission.

Authors:  Anthony Wilson; Philip Scott Mellor; Camille Szmaragd; Peter Paul Clement Mertens
Journal:  Vet Res       Date:  2008-12-19       Impact factor: 3.683

7.  African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.

Authors:  Camilla T Weyer; John D Grewar; Phillippa Burger; Esthea Rossouw; Carina Lourens; Christopher Joone; Misha le Grange; Peter Coetzee; Estelle Venter; Darren P Martin; N James MacLachlan; Alan J Guthrie
Journal:  Emerg Infect Dis       Date:  2016-12-15       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.